Mike King
-
Episode 4 | Meet our Faculty | Mike King
Learn more about Prof. Michael King and his group. The King Lab utilizes nanostructured surfaces and lipid nanoparticles to study the mechanobiology of circulating cancer and immune cells, and for drug delivery strategies to target metastatic cells in the blood and lymphatic circulation. Watch on YouTube |… Read MoreJun. 30, 2023
-
Dissertation Defense: Maria Lopez Cavestany, Biomedical Engineering
DISSERTATION DEFENSE Maria Lopez Cavestany, Biomedical Engineering *under the direction of Mike King “Engineered Models and Therapeutics for Metastatic Colorectal Cancer” 07.05.23 | 2:00PM CST | 134 Featheringill Hall | Zoom In the United States, cancer deaths have dropped by 27% in the last 20 years. Although there has… Read MoreJun. 27, 2023
-
Dissertation Defense: Jenna Dombroski, Biomedical Engineering
DISSERTATION DEFENSE Jenna Dombroski, Biomedical Engineering *under the direction of Mike King “Nano-vaccines and dendritic cell processing for anti-cancer therapies” 05.18.23 | 12:00PM CST | 5326 Stevenson Center | Zoom 1 in 8 women are diagnosed with breast cancer in her lifetime, representing a need for effective preventative measures… Read MoreMay. 9, 2023
-
Innovative engineering method could help defang COVID-19 virus of its spike proteins, leading to new prevention options
Two Vanderbilt engineering professors, including VINSE faculty member Mike King, could revolutionize the treatment of COVID-19 and related viral infections through research using nanotechnology to remove spike proteins from the viruses. Image of the pseudotyped SARS-CoV-2 virus that the Vanderbilt researchers developed to test their liposomes. Michael R. King,… Read MoreApr. 6, 2023
-
“Piezo1 Mechano-Activation Is Augmented by Resveratrol and Differs between Colorectal Cancer Cells of Primary and Metastatic Origin” published in Molecules, selected as VINSE spotlight publication
Josh Greenlee is an NSF Graduate Research Fellow in the Michael King Laboratory where he has spent the last five-and-a-half years working toward his PhD. Josh’s research is focused on understanding mechanisms of metastasis and chemoresistance in colorectal cancer in order to identify weaknesses that can be exploited… Read MoreFeb. 21, 2023
-
Master’s Thesis Presentation: Olivia Wright, Biomedical Engineering
MASTERS RESEARCH PRESENTATION Olivia Wright, Biomedical Engineering *under the direction of Dr. Michael King “Superhydrophobic array devices for the production of a tunable in vitro CTC cluster model” 02.15.23 | 3:30pm | 5326 Stevenson Center Cancer metastasis, the spread cancer to a secondary organ, mainly occurs by tumor… Read MoreFeb. 13, 2023
-
Dissertation Defense, Joshua Greenlee, Biomedical Engineering
DISSERTATION DEFENSE Joshua Dale Greenlee, Biomedical Engineering *under the direction of Dr. Michael King “TRAIL Therapy for Exploiting Mechanisms of Drug Resistance and Metastasis in Advanced Colorectal Cancer” 02.23.23 | 9:30am | Light Hall 208 | Zoom Colorectal cancer (CRC) is the second leading cause of cancer… Read MoreJan. 25, 2023
-
Michael R. King named National Academy of Inventors Fellow
Vanderbilt University engineering professor and VINSE faculty member Michael R. King has been elected a fellow of the National Academy of Inventors. The NAI Fellows Program recognizes academic inventors who have created or facilitated outstanding inventions that make a tangible impact on quality of life, economic development, and the welfare… Read MoreDec. 8, 2022
-
King and Weiss named 2021 AAAS Fellows
Two Vanderbilt engineering faculty members–Sharon Weiss and Michael King–have been elected as 2021 Fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. The lifetime appointment honors individuals for their efforts in advancing science applications that are deemed scientifically or socially distinguished. Election as… Read MoreJan. 26, 2022
-
Spotlight Publication: “Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress” published in Molecular Cancer Therapeutics
“Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress” published in Molecular Cancer Therapeutics has been selected as a VINSE spotlight publication. About the author: Korie Grayson (koriegrayson.com) earner her PhD in Biomedical Engineering in May 2020 from Cornell University under the direction… Read MoreDec. 1, 2021